Software for Method Development of new Chemical and Biologic Entities
Efficiently generating ADME data with rapid turnaround time in a high-throughput drug discovery and development laboratory requires automated LC–MS method optimization without compromising data integrity. DiscoveryQuant 3.0 software simplifies and reduces LC–MS method development cycle time with fast, robust and reliable processes that optimize MRM methods for small or large molecules. It utilizes a global database, enabling shared access across multiple locations within or between companies. The new chromatune feature in DiscoveryQuant 3.0 automates on-column MRM optimization enabling sample analysis during the earliest phase of MRM optimization. This new capability helps identify interferences and reduce false positives in complex matrices before real-sample analysis, which increases laboratory productivity. DiscoveryQuant 3.0 software is supported on all AB SCIEX MS platforms including the TripleTOF high-resolution accurate mass system and seamlessly communicates with MultiQuant™ 3.0 to further leverage data processing capabilities. DiscoveryQuant software ensures success for everyone involved in drug discovery and development.
Speaker: Dr. Mark C Woodward, Investigator, GlaxoSmithKline and Dr. Ian Moore, Applications Scientist, AB SCIEX
In this webinar, you will learn:
How to reduce tedious LC–MS method development time for NCEs and NBEs
How to automate on column optimization
How to rapidly build and submit batches and process results for study samples
How to share database information across multiple sites